German HTA joins critics on WHO trial data disclosure shortcomings
This article was originally published in SRA
Executive Summary
The World Health Organization has faced more criticism that its statement on disclosing clinical trial data does not go far enough if it really wants to make a difference – this time from Germany's health technology appraisal body, IQWiG. Among other things, the WHO needs to work out how it will make organizations comply with its demands, says the IQWiG1.